K. Todaka et al., EFFECT OF BAY-Y-5959 ON MYOCARDIAL-FUNCTION AND METABOLISM IN NORMAL AND FAILING HEARTS, American journal of physiology. Heart and circulatory physiology, 43(5), 1998, pp. 1560-1568
BAY y 5959 is a dihydropyridine derivative with positive inotropic act
ions mediated by a direct increase in intracellular calcium. We charac
terized the direct myocardial actions of this new agent in hearts isol
ated from seven normal dogs and from five dogs with repeated coronary
microembolization-induced heart failure. Inotropic actions of BAY y 59
59 were accompanied by little effect on duration of contraction and by
prolongation of the monophasic action potential (MAP); in contrast, i
soproterenol decreased contraction and MAP durations. Whereas inotropi
c responsiveness to isoproterenol was blunted in embolized hearts, the
se actions of BAY y 5959 were relatively preserved in the heart failur
e state. Isoproterenol increased heart rate, whereas BAY y 5959 had Li
ttle effect. Changes in coronary vascular resistance also decreased si
milarly for isoproterenol and BAY y 5959. Finally, for comparable inot
ropy, increases in myocardial oxygen consumption were similar for isop
roterenol and for BAY y 5959. In summary, preserved inotropic responsi
veness and lack, of positive chronotropic actions are two clinically f
avorable features of this type of inotropic agents compared with a typ
ical beta-adrenergic agonist.